An empirically derived short form of the Hypoglycaemia Fear Survey <scp>II</scp>

Grabman, Jesse H.; Bailey, Kira; Schmidt, K; Cariou, Bertrand; Vaur, L; Madani, Sedigheh; Cox, Daniel J.; Gönder-Frederick, Linda

doi:10.1111/dme.13162

Cited by 35 publications

(33 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Higher scores indicate greater fear of hypoglycaemia. 28 Adequate Cronbach's α values have been reported for the avoidance subscale (0.76), maintain high subscale (0.83), worry subscale (0.78) and total scale (0.83). 28 …”

Section: Methodsmentioning

confidence: 98%

Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey

Bispham

Fan

et al. 2020

BMJ Open

View full text Add to dashboard Cite

ObjectivesFear of hypoglycaemia (FoH) has been associated with suboptimal diabetes management and health outcomes. This study investigated factors associated with behavioural and emotional aspects of FoH among adults living with type 1 diabetes (T1D) mellitus.DesignCross-sectional study.SettingOnline survey hosted on T1D Exchange Glu, an online community for patients living with T1D mellitus.MeasuresThe Hypoglycaemia Fear Survey II-short form and the Hypoglycaemic Attitudes and Behaviour Scale were used to assess FoH. Multivariable regressions were performed on assessment scores.ResultsThe study included 494 participants (mean±SD age 43.9±12.2 years, duration of T1D mellitus 16.6±16.8 years, self-reported glycosylated hemoglobin (HbA1c) 6.9%±0.8% (52±9 mmol/mol)), 63% men, 89% on insulin pump, 25% experienced a severe hypoglycaemic event in the last 6 months. Multivariable regression analyses showed higher anxiety, depression severity and diabetes distress were independently associated with FoH (all p<0.01). Longer diabetes duration was associated with lower FoH (p<0.01). Past experience with severe hypoglycaemia was associated with higher worry of hypoglycaemia (p<0.01) but not avoidance behaviour (ns).ConclusionsThese results highlighted the multifaceted nature of FoH, which warrants further discussion between providers and patients to uncover drivers of and actions required to reduce FoH and improve patient care and outcomes.

show abstract

Section: Methodsmentioning

confidence: 98%

Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey

Bispham

Fan

et al. 2020

BMJ Open

View full text Add to dashboard Cite

show abstract

“…Additionally, incorporating fear of hypoglycemia surveys and recent studies identifying predictors of hypoglycemia would also be clinically useful and relevant. 8182 This will help to provide clinicians with an updated and more precise portrait of the long-term effects of hypoglycemia and contemporary intensive glycemic control.…”

Section: Expert Commentarymentioning

confidence: 99%

Understanding the impact of hypoglycemia on the cardiovascular system

Davis

Ahmadizadeh

Randell

et al. 2017

Expert Review of Endocrinology & Metabolism

View full text Add to dashboard Cite

Introduction Hypoglycemia occurs commonly in insulin requiring individuals with either Type 1 or Type 2 Diabetes. Areas Covered This article will review recent information on the pro-inflammatory and pro-atherothrombotic effects of hypoglycemia. Additionally, effects of hypoglycemia on arrhythmogenic potential and arterial endothelial dysfunction will be discussed. Effects of hypoglycemia on cardiovascular morbidity and mortality from large clinical studies in Type 1 and Type 2 DM will also be reviewed. Expert Commentary The relative and absolute risk of severe hypoglycemia leading to death and serious adverse events in both cardiovascular and other organ systems has been highlighted following the publication of recent large clinical trials focused on glucose control and outcomes. It would be helpful if future studies could develop broader end points to include minor and moderate hypoglycemia as well as more robust methods for capturing hypoglycemia contemporaneously with adverse events. In addition, perhaps consideration of including hypoglycemia as a primary outcome, may help identify the possible cause and effect of hypoglycemia on cardiovascular morbidity and mortality.

show abstract

“…However, the scale not only has many entries, but also lacks clear cutoff value. Moreover, a research found that the internal equity of the behavior subscale is low and has no subjective interpretation related to behavior [[9], [10], [11]]. To this end, Anarte et al.…”

Section: Introductionmentioning

confidence: 99%

Reliability and validity of the Chinese version of the new fear of hypoglycemia scale: FH-15

Liu

Xiong

Sang

et al. 2018

International Journal of Nursing Sciences

View full text Add to dashboard Cite

Objective This study aimed to evaluate the reliability and validity of the Chinese version of the Fear of Hypoglycemia scale with 15 items (FH-15). Methods After obtaining the original author's authorization, the English version of the FH-15 scale was translated, back translated, and culturally debugged to obtain the Chinese version of FH-15. A convenient sampling method was used to extract patients with type 2 diabetes from four tertiary hospitals in Tianjin. A total of 408 patients with type 2 diabetes were investigated in the hospital to test the reliability and validity of Chinese version FH-15 scale. Results The content validity index of the scale was 0.92, and the content validity index of each item was 0.8–1.0. The exploratory factor analysis extracted three common factors (fear, avoidance, and interference), which contained 15 items, and the cumulative variance contribution rate was 71.245%. The confirmatory factor analysis results showed that the model fit was better at 1.981 χ 2 / df , GFI = 0.901, CGI = 0.962, TLI = 0.952, and RMSEA = 0.070. The cut-off value for the total hypoglycemia fear scale was 30.5. The Cronbach's α coefficient of the three dimensions of the scale was 0.918, the Cronbach's α coefficient of each dimension is 0.876–0.916, the test–retest reliability was 0.903, and the test–retest reliability of each factor was 0.733–0.930. Conclusion The Chinese version of the FH-15 scale can be considered reliable and valid. The item expression is concise, clear, and easy to understand. It is suitable for clinical practice as an initial screening tool to identify and evaluate the severity of fear of hypoglycemia in patients with type 2 diabetes.

show abstract

An empirically derived short form of the Hypoglycaemia Fear Survey II

Abstract: The short form of the Hypoglycaemia Fear Survey II is an important first step in more efficiently measuring fear of hypoglycaemia. Future prospective studies are needed for further validity testing and exploring the survey's applicability to different populations.

Cited by 35 publications

References 16 publications

Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey

Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey

Understanding the impact of hypoglycemia on the cardiovascular system

Reliability and validity of the Chinese version of the new fear of hypoglycemia scale: FH-15

Contact Info

Product

Resources

About